PMN - ProMIS Neurosciences Inc.

11.445
-0.085   -0.743%

Share volume: 57,500
Last Updated: 04-20-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.17%

PREVIOUS CLOSE
CHG
CHG%
$11.53
-0.08
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
43%
Profitability 35%
Dept financing 37%
Liquidity 50%
Performance 50%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-3.34%
1 Month
-35.59%
3 Months
38.71%
6 Months
2,499.36%
1 Year
1,918.52%
2 Year
1,386.36%
Key data
Stock price
$11.44
P/E Ratio 
N/A
DAY RANGE
$11.10 - $12.00
EPS 
-$6.82
52 WEEK RANGE
$0.29 - $27.40
52 WEEK CHANGE
$1,779.93
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
8.968 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-13-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$44,176
AVERAGE 30 VOLUME 
$40,310
Company detail
CEO: Gail M. Farfel
Region: US
Website: promisneurosciences.com
Employees: 5
IPO year: 2008
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

N/A

Recent news